(A)Basic characteristics of patients in initial dataset before any omissions. Percentages are related to the total population and are rounded off | |||||
GBS | CIDP | MGUSP | MMN | Total | |
Age groups | |||||
18–50 | 27 | 30 | 5 | 25 | 87 (33%) |
51–63 | 30 | 34 | 12 | 11 | 87 (33%) |
64 and older | 28 | 24 | 26 | 12 | 90 (34%) |
Gender | |||||
Female | 35 | 25 | 11 | 10 | 81 (31%) |
Male | 50 | 63 | 32 | 38 | 183 (69%) |
Total | 85 (32%) | 88 (33%) | 43 (16%) | 48 (18%) | 264 (100%) |
(B) Basic characteristics of patients used in final IN-QoL questionnaire. Percentages are related to the total population and are rounded off | |||||
Age groups | |||||
18–50 | 21 | 25 | 4 | 23 | 73 (31%) |
51–63 | 24 | 34 | 15 | 13 | 86 (37%) |
64 and older | 23 | 20 | 22 | 11 | 76 (32%) |
Gender | |||||
Female | 30 | 22 | 10 | 10 | 72 (31%) |
Male | 38 | 57 | 31 | 37 | 163 (69%) |
Total | 68 (29%) | 79 (34%) | 41 (17%) | 47 (20%) | 235 (100%) |
(C)Basic characteristics of patients from longitudinal dataset to determine responsiveness. Percentages are related to the total population and are rounded off | |||||
Age groups | |||||
18–50 | 13 | 12 | 2 | 8 | 35 (35%) |
51–63 | 9 | 16 | 6 | 4 | 35 (35%) |
64 and older | 7 | 11 | 9 | 4 | 31 (31%) |
Gender | |||||
Female | 10 | 11 | 6 | 4 | 31 (31%) |
Male | 19 | 28 | 11 | 12 | 70 (69%) |
Total | 29 (29%) | 39 (39%) | 17 (17%) | 16 (16%) | 101 (100%) |
CIDP, chronic inflammatory demyelinating polyradiculopathy; GBS, Guillain-Barré syndrome;IN-QoL, QoL questionnaire in inflammatory neuropathies; MGUSP, monoclonal gammopathy-related polyneuropathy; MMN, multifocal motor neuropathy.